Stock listing

Medmira Inc.

Selected listing: 47M · FWB · EUR · DE

Medmira Inc. (Frankfurt:47M), Health Technology. Latest release Jun 30, 2026: MedMira Reports Third Quarter Results FY2026.

47M:FWBEURDEUpdated October 2, 2026

Ticker: Frankfurt:47M
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Frankfurt
Currency: EUR

About Medmira Inc.

The company specializes in the development and commercialization of rapid diagnostic tests. Medmira aims to improve healthcare outcomes through innovative testing solutions.

Latest news from Medmira Inc.

MedMira Reports Third Quarter Results FY2026

June 29, 2026

MedMira Reports First Quarter Results FY2026

December 30, 2025

MedMira Reports FY2025 Fourth Quarter and Year End Financial Results

November 28, 2025

Health Canada Approves MedMira's Reveal(R) Rapid TP Test - Urgent New Tool In The Battle Against Syphilis

August 26, 2025

MedMira Announces Launch of Clinical Trial for Its Multiplo(R) TP/HIV Self-Test in Canada

July 7, 2025

All Medmira Inc. news →

Research Medmira Inc.

Medmira Inc. company profile

View the public company page for Medmira Inc. on 6ix.

Medmira Inc. news

Read company news and market updates connected to Medmira Inc..

Medmira Inc. investor events

Find investor webinars, events, and replay context for Medmira Inc..